These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6121516)

  • 1. [Malignant melanoma - adjuvant systemic therapy].
    Schreml W
    Aktuelle Probl Chir Orthop; 1982; 22():64-5. PubMed ID: 6121516
    [No Abstract]   [Full Text] [Related]  

  • 2. Combating melanoma: the use of photodynamic therapy as a novel, adjuvant therapeutic tool.
    Davids LM; Kleemann B
    Cancer Treat Rev; 2011 Oct; 37(6):465-75. PubMed ID: 21168280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS; Neuberg D; Park Y; Kirkwood JM
    Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinostatic action of synthetic polymers on transplantable tumors].
    Korosteleva TA; Movsesian KA; Meiia NV; Nesterova VI; Sorokin AIa
    Vopr Onkol; 1982; 28(6):39-41. PubMed ID: 7090295
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adjuvant therapy of bronchial carcinoma with special attention to immunotherapy].
    Drings P
    Aktuelle Probl Chir Orthop; 1982; 22():30-5. PubMed ID: 6121510
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic treatment of malignant melanoma.
    Mota A; Deisseroth A
    Clin Plast Surg; 2000 Jul; 27(3):463-74, x. PubMed ID: 10941566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy of malignant melanoma.
    Dickler MN; Coit DG; Meyers ML
    Surg Oncol Clin N Am; 1997 Oct; 6(4):793-812. PubMed ID: 9309094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant application of interferons.
    el Kassas H; Kirkwood JM
    Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case of malignant melanoma of the external genitalia responding satisfactorily to a combination of local injection of OK-432 and chemotherapy].
    Satoh S; Suzuki A; Okamura H; Nishimura T
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):140-5. PubMed ID: 6820877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma and chemotherapy.
    Aust JB
    Prog Clin Cancer; 1975; 6():199-204. PubMed ID: 53859
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase 1 study of granulocyte macrophage colony-stimulating factor (sargramostim) and escalating doses of thalidomide in patients with high-risk malignant melanoma.
    Lutzky J; Weber R; Nunez Y; Gillett M; Spitler L
    J Immunother; 2009 Jan; 32(1):79-85. PubMed ID: 19307996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy of malignant melanoma based on a cell culture test].
    Tveit KM; Gundersen S; Vaage S
    Tidsskr Nor Laegeforen; 1983 Jan; 103(2):117-9. PubMed ID: 6845300
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant therapy for melanoma.
    Sondak VK
    Cancer J; 2001; 7 Suppl 1():S24-7. PubMed ID: 11504282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma.
    Wong SF; Jakowatz JG; Taheri R
    Ann Pharmacother; 2004 Oct; 38(10):1655-9. PubMed ID: 15304625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma.
    Schwartsmann G; Parkinson DR
    Cancer Chemother Biol Response Modif; 1993; 14():577-93. PubMed ID: 8312120
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant high-dose interferon therapy for high-risk melanoma.
    Ready N; Weinstock MA
    Arch Dermatol; 2003 Dec; 139(12):1635-7. PubMed ID: 14676083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.